Drawing for RECEPTOR

USPTO serial 86913299

RECEPTOR

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BURNS, ELLEN
Law office
TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 600: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with RECEPTOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sally Abel

Sally Abel Fenwick & West LLP801 California StreetMountain View, CA 94041UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for human use for the treatment of pain, central nervous systems, metabolic disorders, gastrointestinal disorders, for use in side effects from chemotherapy; inhalers sold pre-filled with pharmaceutical preparations; namely, pharmaceutical preparations with plant extracts for the treatment of pain, central nervous systems, metabolic disorders, gastrointestinal disorders and for use in side effects from chemotherapy; plant extracts for pharmaceutical purposesACTIVE—
042scientific and medical research relating to the diagnosis and treatment of medical conditions; scientific and medical research relating to plant extracts for pharmaceutical purposesACTIVE—
044providing a website featuring information relating to the diagnosis and treatment of medical conditionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 27, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 27, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 27, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 27, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 27, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 1, 2019MAB0ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE—
Mar 29, 2019ABN0ABANDONMENT - INCOMPLETE RESPONSE—
Mar 21, 2019RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Sep 11, 2018RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 2, 2018RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Aug 30, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 30, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Aug 30, 2017CNSLSUSPENSION LETTER WRITTEN—
Jul 26, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 26, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 24, 2017ALIEASSIGNED TO LIE—
Jun 19, 2017ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Dec 21, 2016GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 21, 2016GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 21, 2016CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 30, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 29, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 29, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 29, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 29, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 29, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 19, 2016DOCKASSIGNED TO EXAMINER—
Feb 25, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 23, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance